S-1: Crown Electrokinetics Eyes $100 Million Capital Injection Through Stock Purchase Agreement with Liqueous LP

Crown Electrokinetics Corp. files for a resale registration statement, paving the way for potential sales of up to $100 million in common stock to Liqueous LP under a recently established purchase agreement.

Summary

• Crown Electrokinetics Corp. has entered into a stock purchase agreement with Liqueous LP, potentially allowing the company to sell up to $100 million in common stock.
• The company has filed a registration statement to allow Liqueous LP to resell these shares.
• Crown Electrokinetics will not initially receive any proceeds from the resale of shares by Liqueous LP, but may receive up to $100 million from the sale of its common stock to Liqueous LP under the Purchase Agreement.
• The company intends to use any proceeds from the Selling Stockholder that we receive under the Purchase Agreement for working capital, strategic and general corporate purposes.
• The agreement allows Crown Electrokinetics to issue shares to Liqueous LP over a 24-month period, subject to certain conditions.
• The purchase price per share will be 97% of the lowest daily VWAP during the two business days prior to the purchase date.
• The company is registering 20,000,000 shares for resale, exceeding the initial exchange cap, which was addressed with stockholder approval on June 14, 2024.
• The company's common stock is listed on the Nasdaq Capital Market under the symbol CRKN.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the agreement provides potential access to capital, it also carries risks of dilution and market volatility. The company's ability to effectively utilize the funds will determine the ultimate impact.

Positives

• The agreement provides Crown Electrokinetics with access to potential capital of up to $100 million.
• The company has obtained stockholder approval to issue shares beyond the initial exchange cap.
• The company retains control over the timing and amount of stock sales to Liqueous LP.
• The company intends to use any proceeds from the Selling Stockholder that we receive under the Purchase Agreement for working capital, strategic and general corporate purposes.

Negatives

• The company will not initially receive any proceeds from the resale of shares by Liqueous LP.
• The purchase price per share to be paid by the Selling Stockholder for the shares of Common Stock that we may elect to sell to them under the Purchase Agreement, if any, will fluctuate based on the market prices of our Common Stock for each Purchase made pursuant to the Purchase Agreement.
• The extent to which we rely on the Selling Stockholder as a source of funding will depend on a number of factors including, the prevailing market price of our Common Stock and the extent to which we are able to secure working and other capital from other sources.
• Future sales and issuances of our Common Stock or other securities might result in significant dilution and could cause the price of our Common Stock to decline.

Risks

• The market price of the company's common stock could be negatively affected by sales of shares by Liqueous LP.
• The company may need to register additional shares for resale if the initial registration is insufficient to cover the full $100 million commitment.
• The company's reliance on Liqueous LP for funding depends on various factors, and alternative funding sources may be needed.
• The company may not be able to continue operations without additional financing.

Future Outlook

The company anticipates using the proceeds from the stock purchase agreement for working capital, strategic initiatives, and general corporate purposes.

Industry Context

The announcement reflects a company seeking capital to fund its operations and growth, a common practice in the technology and manufacturing sectors. The use of a stock purchase agreement with an investment firm is a typical method for raising capital, but can also introduce risks related to stock dilution and market volatility.

Comparison to Industry Standards

• Comparable companies in the smart glass industry, such as View, Inc. and Research Frontiers, Inc., have also utilized public offerings and strategic partnerships to secure funding.
• View, Inc., for example, went public through a SPAC merger and has raised capital through debt and equity offerings.
• Research Frontiers licenses its SPD technology and generates revenue through royalties, a different business model than Crown's direct sales approach.
• The $100 million commitment is significant for a company of Crown Electrokinetics' size, but the actual amount raised will depend on market conditions and the company's decisions regarding stock sales.

Stakeholder Impact

• Shareholders may experience dilution if the company issues a significant number of shares to Liqueous LP.
• The company's employees and customers may benefit from the increased financial stability and growth potential resulting from the capital injection.
• The company's suppliers and creditors may see improved payment terms and increased business opportunities.

Next Steps

• The company needs to ensure the registration statement becomes and remains effective.
• The company will need to manage the timing and amount of stock sales to Liqueous LP to minimize market impact.
• The company will need to effectively deploy the raised capital to achieve its strategic goals.

Key Dates

Keywords

stock purchase agreement, Liqueous LP, Crown Electrokinetics, registration statement, common stock, capital raise, resale, VWAP, shares, financing